Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Perfuze logo — Neurovascular medical device company developing technology f...

Perfuze

Neurovascular medical device company developing technology for Ischemic Stroke

Founded 2018 Ireland Ireland 33 employees Series A Total: $25.50M Biotechnology, Health Care +1

General Information

Company Name Perfuze
Founded Year 2018
Location Ireland Ireland
Employees 33
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Perfuze. To contact Perfuze, visit perfuze.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Perfuze compare?

A PDF of Perfuze and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Perfuze soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Perfuze

Perfuze is a neurovascular medical device company founded in 2018 and based in Ireland. The company's slogan focuses on developing technology for Ischemic Stroke, a critical area within the biotechnology, healthcare, and medical devices industries.

Perfuze recently secured a significant €22.50M Series A investment on 09 February 2022, with participation from notable investors including Earlybird, SV Health Investors, Seroba Life Sciences, HBM-MedFocus, LSP Health Economics Fund, EQT Life Sciences, and Medtech Convergence Fund.

As a promising player in the neurovascular medtech startup landscape, Perfuze's recent funding round is a testament to the confidence of prominent investors in the company's innovative approach to addressing Ischemic Stroke. This infusion of capital is expected to fuel the company's growth and advance its mission of developing impactful medical solutions in the neurovascular space.

Taxonomy: Neurovascular, Ischemic Stroke, Medical Device, Medtech, Catheter Technology, Clinical Outcomes, R&D, Innovative Technology, Acute Stroke Treatment, Business Innovation, Start-up Experience, Procedural Efficiency, Cost-effective Therapy

Services & Products

Development and manufacturing of advanced superbore aspiration technology for ischemic stroke treatment

Target Customers

Hospitals healthcare institutions neurointerventional specialists stroke treatment centers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €22.50M 7
Earlybird SV Health Investors Seroba Life Sciences
Earlybird, SV Health Investors +5
09 Feb 2022
Seed Round €3.00M 3
Enterprise Ireland Early Capital Berrywood MedFocus Fund
Enterprise Ireland, Early Capital Berrywood +1
29 Jan 2019

Perfuze Alternatives & Competitors

View All Alternatives
Perfuze vs
MIVI Neuroscience, Inc
MIVI Neuroscience, Inc United States

The Next Generation of Neurointervention

Series B
18 employees
Health Care, Medical Devices
Compare Perfuze vs MIVI Neuroscience, Inc
Perfuze vs
Time is Brain
Time is Brain Spain

Our medical device BraiN20 adresses the best management of Acute Ischemic Stroke | Neurology | Strok...

Pre-Seed
15 employees
Health Care, Medical Devices
Compare Perfuze vs Time is Brain
Perfuze vs
WallabyPhenox
WallabyPhenox Germany

Leading Innovator in Interventional Neuroradiology

Acquired
225 employees
Biotechnology, Medical Devices
View all alternatives

FAQ About Perfuze

Neurovascular medical device company developing technology for Ischemic Stroke
Perfuze was founded in 2018.
Perfuze is headquartered in Ireland.
Perfuze operates in Biotechnology, Health Care and Medical Devices. Its work centres on Neurovascular, Ischemic Stroke, Medical Device and Medtech. Its customers include Hospitals, healthcare institutions and neurointerventional specialists.
Perfuze has approximately 33 employees.
Perfuze has completed 2 funding rounds, raising a total of $25.50M. The latest funding stage is Series A.
Perfuze offers: Development and manufacturing of advanced superbore aspiration technology for ischemic stroke treatment.
Top alternatives and competitors to Perfuze include MIVI Neuroscience, Inc, Time is Brain, WallabyPhenox, Acthera Therapeutics Ltd., Revamp Medical Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Perfuze and MIVI Neuroscience, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Perfuze, https://bouncewatch.com/company/perfuze, updated 25 February 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes